Serum fibroblast growth factor 23 is a useful marker to distinguish vitamin d-deficient rickets from hypophosphatemic rickets

Hormone Research in Paediatrics

Volumn 81, Issue 4, 2014, Pages 251-257

  Kubota, Takuo ^a,b   Kitaoka, Taichi ^a   Miura, Kohji ^a   Fujiwara, Makoto ^a   Ohata, Yasuhisa ^a   Miyoshi, Yoko ^a   Yamamoto, Keiko ^a   Takeyari, Shinji ^c   Yamamoto, Takehisa ^c   Namba, Noriyuki ^a   Ozono, Keiichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Minoh City Hospital   (Japan)

Author keywords

Children; Fibroblast growth factor 23; Hypophosphatemia; Rickets; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE; FIBROBLAST GROWTH FACTOR; CREATININE;

ADOLESCENT; ARTICLE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CHILD; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPOPHOSPHATEMIC RICKETS; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RICKETS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D DEFICIENT RICKETS; BLOOD; COMPLICATION; DIFFERENTIAL DIAGNOSIS; INFANT; PRESCHOOL CHILD; RICKETS, HYPOPHOSPHATEMIC; BREAST FEEDING; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; FAMILIAL HYPOPHOSPHATEMIC RICKETS; PHOSPHATE URINE LEVEL; SUN EXPOSURE; TREATMENT RESPONSE;

CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INFANT; MALE; RICKETS; RICKETS, HYPOPHOSPHATEMIC; VITAMIN D DEFICIENCY;

EID: 84901602139     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000357142     Document Type: Article

References (29)

1. Mughal MZ: Rickets. Curr Osteoporos Rep 2011; 9: 291-299.
2. Wharton B, Bishop N: Rickets. Lancet 2003; 362: 1389-1400.
3. Absoud M, Cummins C, Lim MJ, Wassmer E, Shaw N: Prevalence and predictors of vitamin D insufficiency in children: a Great Britain population based study. PLoS One 2011; 6:e22179.
4. Carpenter TO, Herreros F, Zhang JH, Ellis BK, Simpson C, Torrealba-Fox E, Kim GJ, Savoye M, Held NA, Cole DE: Demographic, dietary, and biochemical determinants of vitamin D status in inner-city children. Am J Clin Nutr 2012; 95: 137-146.
5. Cesur Y, Dogan M, Ariyuca S, Basaranoglu M, Bektas MS, Peker E, Akbayram S, Caksen H: Evaluation of children with nutritional rickets. J Pediatr Endocrinol Metab 2011; 24: 35-43.
6. Akazawa Y, Shiohara M, Amano Y, Uchida N, Nakamura S, Minami I, Yasui K, Kurata K, Koike K: The clinical characteristics of vitamin D deficiency in childhood: a systematic literature review of Japanese patients. J Pediatr Endocrinol Metab 2010; 23: 675-684.
7. Matsuo K, Mukai T, Suzuki S, Fujieda K: Prevalence and risk factors of vitamin D deficiency rickets in Hokkaido, Japan. Pediatr Int 2009; 51: 559-562.
8. Yorifuji J, Yorifuji T, Tachibana K, Nagai S, Kawai M, Momoi T, Nagasaka H, Hatayama H, Nakahata T: Craniotabes in normal newborns: the earliest sign of subclinical vitamin D deficiency. J Clin Endocrinol Metab 2008; 93: 1784-1788.
9. Kubota T, Kotani T, Miyoshi Y, Santo Y, Hirai H, Namba N, Shima M, Shimizu K, Nakajima S, Ozono K: A spectrum of clinical presentations in seven Japanese patients with vitamin D deficiency. Clin Pediatr Endocrinol 2006; 15: 23-28.
10. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930.
11. Wimalawansa SJ: Vitamin D in the new millennium. Curr Osteoporos Rep 2012; 10: 4-15.
12. Saintonge S, Bang H, Gerber LM: Implications of a new definition of vitamin D deficiency in a multiracial US adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics 2009; 123: 797-803.
13. Wagner CL, Greer FR: Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008; 122: 1142-1152.
14. Holick MF: Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062-2072.
15. Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL: A clinician's guide to Xlinked hypophosphatemia. J Bone Miner Res 2011; 26: 1381-1388.
16. Carpenter TO: The expanding family of hypophosphatemic syndromes. J Bone Miner Metab 2011; 30: 1-9.
17. Quarles LD: Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol 2012; 8: 276-286.
18. Feng JQ, Clinkenbeard EL, Yuan B, White KE, Drezner MK: Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia. Bone 2013; 54: 213-221.
19. Fukumoto S: The role of bone in phosphate metabolism. Mol Cell Endocrinol 2009; 310: 63-70.
20. Fujiwara M, Namba N, Ozono K, Arisaka O, Yokoya S; Committee on Drugs, Japanese Society for Pediatric Endocrinology: Treatment of hypophosphatemic rickets with phosphate and active vitamin D in Japan: a questionnaire-based survey Clin Pediatr Endocrinol 2013; 22: 9-14.
21. Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T: Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone 2008; 42: 1235-1239.
22. Stark H, Eisenstein B, Tieder M, Rachmel A, Alpert G: Direct measurement of TP/GFR: a simple and reliable parameter of renal phosphate handling. Nephron 1986; 44: 125-128.
23. Alon U, Hellerstein S: Assessment and interpretation of the tubular threshold for phosphate in infants and children. Pediatr Nephrol 1994; 8: 250-251.
24. Uzum AK, Salman S, Telci A, Boztepe H, Tanakol R, Alagol F, Ozbey NC: Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term. Eur J Endocrinol 2010; 163: 825-831.
25. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S: Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 2002; 87: 4957-4960.
26. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H: Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003; 348: 1656-1663.
27. Mimouni FB, Shamir R: Vitamin D requirements in the first year of life. Curr Opin Clin Nutr Metab Care 2009; 12: 287-292.
28. Penido MG, Alon US: Phosphate homeostasis and its role in bone health. Pediatr Nephrol 2012; 27: 2039-2048.
29. Martin A, David V, Quarles LD: Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 2012; 92: 131-155.